Prevalence of Germline BRCA1 and BRCA2 Deleterious Mutations in Brazilian Patients with High-Risk of Breast and Ovarian Cancer.

被引:0
|
作者
Diz, M. D. P. E. [1 ]
Escobar, K. A. [1 ]
Guindalini, R. S. C. [1 ]
Pasini, F. S. [1 ]
Snitkoyiski, M. L. [1 ]
Maistro, S. [1 ]
Hoff, P. M. G. [1 ]
Federico, M. H. H. [1 ]
机构
[1] Inst Canc Estado Sao Paulo, Sao Paulo, Brazil
关键词
D O I
10.1158/0008-5472.SABCS11-P2-13-07
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P2-13-07
引用
收藏
页数:2
相关论文
共 50 条
  • [1] High prevalence of deleterious BRCA1 and BRCA2 germline mutations in arab breast and ovarian cancer patients
    Al-Joharah Alhuqail
    Areej Alzahrani
    Hannah Almubarak
    Sarah Al-Qadheeb
    Lamyaa Alghofaili
    Nisreen Almoghrabi
    Hamed Alhussaini
    Ben Ho Park
    Dilek Colak
    Bedri Karakas
    Breast Cancer Research and Treatment, 2018, 168 : 695 - 702
  • [2] High prevalence of deleterious BRCA1 and BRCA2 germline mutations in arab breast and ovarian cancer patients
    Alhuqail, Al-Joharah
    Alzahrani, Areej
    Almubarak, Hannah
    Al-Qadheeb, Sarah
    Alghofaili, Lamyaa
    Almoghrabi, Nisreen
    Alhussaini, Hamed
    Park, Ben Ho
    Colak, Dilek
    Karakas, Bedri
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 168 (03) : 695 - 702
  • [3] Germline BRCA1 and BRCA2 mutations in Brazilian ovarian and breast cancer patients.
    Maistro, Simone
    Encinas, Giselly
    Nagy, Tauana
    Teixeira, Natalia
    Katayama, Maria Lucia H.
    Gouvea, Ana Carolina R. C.
    Diz, Maria del Pilar E.
    Chammas, Roger
    de Boch, Geertruida H.
    Folgueira, Maria Aparecida A. K.
    CLINICAL CANCER RESEARCH, 2018, 24 (01) : 31 - 31
  • [4] Spectrum and characterisation of BRCA1 and BRCA2 deleterious mutations in high-risk Czech patients with breast and/or ovarian
    Machackova, Eva
    Foretova, Lenka
    Lukesova, Mirka
    Vasickova, Petra
    Navratilova, Marie
    Coene, Ilse
    Pavlu, Hana
    Kosinova, Veronika
    Kuklova, Jitka
    Claes, Kathleen
    BMC CANCER, 2008, 8 (1)
  • [5] Prevalence of BRCA1 and BRCA2 Mutations Among High-Risk Saudi Patients With Breast Cancer
    Abulkhair, Omalkhair
    Al Balwi, Mohammed
    Makram, Ola
    Alsubaie, Lamia
    Faris, Medhat
    Shehata, Hussam
    Hashim, Ahmed
    Arun, Banu
    Saadeddin, Ahmed
    Ibrahim, Ezzeldin
    JOURNAL OF GLOBAL ONCOLOGY, 2018, 4
  • [6] Prevalence of BRCA1 and BRCA2 gene mutations in Chinese patients with high-risk breast cancer
    Wang, Xiaozhen
    Liu, Haimeng
    Maimaitiaili, Amina
    Zhao, Gang
    Li, Sijie
    Lv, Zheng
    Wu, Di
    Shi, Aiping
    Guan, Xin
    Jia, Hongyao
    Li, Menghan
    Song, Dong
    Kang, Lihua
    Han, Bing
    Fu, Tong
    Yang, Ming
    Zhu, Zhu
    Du, Ye
    Song, Yanqiu
    Hong, Jinghui
    Fan, Zhimin
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2019, 7 (06):
  • [7] Management of Breast Cancer Risk in Women with Ovarian Cancer and Deleterious BRCA1 or BRCA2 Mutations
    Hendrickson, Andrea E. Wahner
    Bakkum-Gamez, Jamie N.
    Couch, Fergus J.
    Ghosh, Karthik
    Boughey, Judy C.
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (11) : 3107 - 3109
  • [8] Management of Breast Cancer Risk in Women with Ovarian Cancer and Deleterious BRCA1 or BRCA2 Mutations
    Andrea E. Wahner Hendrickson
    Jamie N. Bakkum-Gamez
    Fergus J. Couch
    Karthik Ghosh
    Judy C. Boughey
    Annals of Surgical Oncology, 2017, 24 : 3107 - 3109
  • [9] Mathematical modeling for prediction of secondary BRCA1 and BRCA2 mutations in ovarian cancers with deleterious germline BRCA1 and BRCA2 mutations
    Botesteanu, Dana-Adriana
    Levy, Doron
    Lee, Jung-Min
    CANCER RESEARCH, 2016, 76
  • [10] Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients
    Rashid, Muhammad U.
    Zaidi, Anbreen
    Torres, Diana
    Sultan, Faisal
    Benner, Axel
    Naqvi, Bilal
    Shakoori, Abdul R.
    Seidel-Renkert, Antje
    Farooq, Humirah
    Narod, Steven
    Amin, Asim
    Hamann, Ute
    INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (12) : 2832 - 2839